Parent Project Muscular Dystrophy Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2011
NCT01359670
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

raav1.cmv.hufollistatin344 (1 trial)

Drugs in Other Trials (2)

sildenafil (viagra) (1 trial)

tadalafil (cialis) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Muscular Dystrophies (Phase 1)

Muscular Dystrophy, Duchenne (Phase 1)

Myositis (Phase 1)

Myositis, Inclusion Body (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 3